Upcoming Event in Netherlands from Mar 19 to Mar 21, 2025
XL t(1;19) PBX1/TCF3 DF
Translocation/Dual Fusion Probe
- Order Number
- D-5153-100-OG
- Package Size
- 100 µl (10 Tests)
- Regulatory Status
- RUO
XL t(1;19) PBX1/TCF3 DF consists of an orange-labeled probe hybridizing to the PBX1 gene region at 1q23.3 and a green-labeled probe hybridizing to the TCF3 (E2A) gene region at 19p13.
Please note that this product is not classified as an IVD product in the EU according to the REGULATION (EU) 2017/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU. It is marked as for ´Research Use Only´ (RUO).
Probe maps for selected products have been updated. These updates ensure a consistent presentation of all gaps larger than 10 kb including adjustments to markers, genes, and related elements. This update does not affect the device characteristics or product composition. Please refer to the list to find out which products now include updated probe maps.
Probe map details are based on UCSC Genome Browser GRCh37/hg19, with map components not to scale.
XL t(1;19) PBX1/TCF3 DF hybridized to lymphocytes. Two normal interphases are shown.
Normal Cell:
Two green (2G) and two orange (2O) signals.
Aberrant Cell (typical results):
One green (1G), one orange (1O), and two green-orange fusion (2GO) (adjacent green and orange) signals.
Our Complete Set of XA Aneusomy Probes for Prenatal Testing Is IVDR Certified.
MetaSystems Probes has received IVDR certification for our XCyting FISH probes for prenatal aneusomy testing – the XA aneusomy probes.
Feb 1, 2025: Rollout of IVDR-certified XCyting FISH Probes!
The first phase of this rollout includes the following countries: Austria, Cyprus, Estonia, Germany, Iceland and The Netherlands. More countries will be supplied over time.
